2-Amino-3-bromopyrazine

Catalog No.: 
ACRWOG738
CAS No.: 
21943-12-4
Molecular Formula: 
C4H4BrN3
Molecular Weight: 
174.00
2-Amino-3-bromopyrazine structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
10g95%$81.00In stockInquiry
25g95%$176.00In stockInquiry
100g95%$538.00In stockInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name2-Amino-3-bromopyrazine
IUPAC Name3-bromopyrazin-2-amine
MDL No.MFCD09909692
Molecular FormulaC4H4BrN3
Molecular Weight174.00
SMILESNC1=NC=CN=C1Br
InChI KeyBFEUGUAUYFATRV-UHFFFAOYSA-N
SynonymMFCD09909692 | 3-bromopyrazin-2-amine | BFEUGUAUYFATRV-UHFFFAOYSA-N | BCP23405 | DTXSID40563422 | STL555293 | SCHEMBL557517 | 3-bromo-pyrazin-2-ylamine | BBL101497 | C4H4BrN3 | 3-BROMO-2-PYRAZINAMINE | Bromopyrazin-2-amine | 2-Amino-3-bromopyrazine | CHEM
CAS No.21943-12-4
PubChem CID14735942

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H332-H335
Precautionary Statement(s)
P261-P280-P305+P351+P338

Synthetic Route by SureRoute

1. ACRWOG738 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACPUAB103 route compound structure diagram
    ACPUAB10395538-03-7In Stock
  2. Plus
  3. ACAYOL972 route compound structure diagram
    ACAYOL97210060-13-6In Stock
  4. Then
  5. ACRWOG738 route product structure diagram
    ACRWOG73821943-12-4In Stock
Inquiry

2. ACRWOG738 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. ACOIJY845 route compound structure diagram
    ACOIJY845212779-21-0In Stock
  2. Then
  3. ACRWOG738 route product structure diagram
    ACRWOG73821943-12-4In Stock
Inquiry

3. ACRWOG738 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACRWOG738 route product structure diagram
    ACRWOG73821943-12-4In Stock
Inquiry

Comments (0)